dronabinol and am 281
dronabinol has been researched along with am 281 in 15 studies
Research
Studies (15)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (80.00) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Drmota, T; Elebring, T; Greasley, PJ; Hermansson, NO; Hjorth, S; Larsson, N; Leonova, J; Nilsson, K; Ryberg, E; Sjögren, S | 1 |
| Bowen, RC; Cui, SS; Gu, GB; Hannesson, DK; Yu, PH; Zhang, X | 1 |
| Chow, SS; Lau, AH | 1 |
| Goodchild, AK; Li, Q; Padley, JR; Pilowsky, PM | 1 |
| Bertolini, A; Ferrari, A; Leone, S; Ottani, A; Sandrini, M | 1 |
| Hader, W; Yang, C; Zhang, X | 1 |
| Drysdale, AJ; Pertwee, RG; Platt, B; Ryan, D | 1 |
| Goonawardena, AV; Hampson, RE; Pertwee, RG; Riedel, G; Robinson, L | 1 |
| Baraban, JM; Han, S; Miskimon, M; Reti, IM; Rosen, JB | 1 |
| Fuchs, D; Jenny, M; Pirich, E; Santer, E; Schennach, H | 1 |
| Börner, C; Höllt, V; Kraus, J; Schraven, B; Smida, M | 1 |
| Haskó, G; Liaudet, L; Mackie, K; Mukhopadhyay, P; Pacher, P; Rajesh, M | 1 |
| Müller-Vahl, KR | 1 |
| Gomez, O; Le, M; Molina-Holgado, E; Molina-Holgado, F; Sanchez-Caro, C; Sanchez-Rodriguez, A | 1 |
| Denovan-Wright, EM; Kelly, ME; Laprairie, RB | 1 |
Other Studies
15 other study(ies) available for dronabinol and am 281
| Article | Year |
|---|---|
The orphan receptor GPR55 is a novel cannabinoid receptor.
Topics: Amino Acid Sequence; Animals; Arachidonic Acids; Binding Sites; Binding, Competitive; Cannabidiol; Cannabinoids; Cell Line; Cloning, Molecular; Cyclohexanols; Down-Regulation; Endocannabinoids; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Ligands; Mice; Molecular Sequence Data; Organ Specificity; Polymerase Chain Reaction; Polyunsaturated Alkamides; Rats; Receptors, Cannabinoid; Receptors, G-Protein-Coupled; RNA, Messenger; Signal Transduction; Structure-Activity Relationship | 2007 |
Prevention of cannabinoid withdrawal syndrome by lithium: involvement of oxytocinergic neuronal activation.
Topics: Animals; Behavior, Animal; Brain; Camphanes; Cannabinoids; Densitometry; Dose-Response Relationship, Drug; Dronabinol; Immunohistochemistry; In Situ Hybridization; Lithium; Male; Morpholines; Neurons; Oxytocin; Piperazines; Proto-Oncogene Proteins c-fos; Pyrazoles; Radioimmunoassay; Rats; Rats, Long-Evans; Receptors, Cannabinoid; Receptors, Drug; Receptors, Oxytocin; Substance Withdrawal Syndrome | 2001 |
Effects of cannabinoid receptor agonists on immunologically induced histamine release from rat peritoneal mast cells.
Topics: Adjuvants, Immunologic; Amides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Anti-Idiotypic; Arachidonic Acids; Benzoxazines; Cannabinoid Receptor Modulators; Dose-Response Relationship, Drug; Dronabinol; Drug Synergism; Endocannabinoids; Ethanolamines; Histamine Release; Immunoglobulin E; Male; Mast Cells; Morpholines; Naphthalenes; Ovalbumin; Palmitic Acids; Peritoneal Cavity; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug | 2003 |
Cannabinoid receptor activation in the rostral ventrolateral medulla oblongata evokes cardiorespiratory effects in anaesthetised rats.
Topics: Anesthesia; Animals; Benzoxazines; Blood Pressure; Cannabinoid Receptor Agonists; Cannabinoids; Dose-Response Relationship, Drug; Dronabinol; Gene Expression; Heart Rate; Ligands; Male; Medulla Oblongata; Microinjections; Morpholines; Naphthalenes; Neuroprotective Agents; Phrenic Nerve; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Respiratory Mechanics; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Splanchnic Nerves | 2003 |
The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Dose-Response Relationship, Drug; Dronabinol; Male; Morpholines; Nociceptors; Pain Measurement; Pain Threshold; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant | 2006 |
Therapeutic action of cannabinoid on axonal injury induced by peroxynitrite.
Topics: Adrenalectomy; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Axons; Brain Diseases; Cannabinoids; Corpus Callosum; Corticosterone; Disease Models, Animal; Dronabinol; Drug Therapy, Combination; Enzyme Inhibitors; Immunohistochemistry; Male; Molsidomine; Morpholines; Peroxynitrous Acid; Pyrazoles; Rats; Rats, Wistar | 2006 |
Interactions of cannabidiol with endocannabinoid signalling in hippocampal tissue.
Topics: Animals; Arachidonic Acids; Benzamides; Calcium; Cannabidiol; Cannabinoid Receptor Modulators; Carbamates; Cells, Cultured; Dronabinol; Endocannabinoids; Estrenes; Glutamic Acid; Glycerides; Hippocampus; Humans; Morpholines; Pertussis Toxin; Phosphodiesterase Inhibitors; Polyunsaturated Alkamides; Pyrazoles; Pyrrolidinones; Rats; Receptor, Cannabinoid, CB1; Signal Transduction | 2007 |
The synthetic cannabinoid HU210 induces spatial memory deficits and suppresses hippocampal firing rate in rats.
Topics: Animals; Behavior, Animal; Cannabinoids; Dronabinol; Electrophysiology; Hippocampus; Male; Maze Learning; Memory; Memory Disorders; Morpholines; Motor Activity; Neurons; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Rimonabant; Space Perception | 2007 |
Nicotine and Delta(9)-tetrahydrocannabinol withdrawal induce Narp in the central nucleus of the amygdala.
Topics: Amygdala; Animals; C-Reactive Protein; Cell Count; Dronabinol; Male; Morpholines; Nerve Tissue Proteins; Neurons; Nicotine; Pyrazoles; Rats; Stress, Psychological; Substance Withdrawal Syndrome | 2009 |
Delta9-tetrahydrocannabinol and cannabidiol modulate mitogen-induced tryptophan degradation and neopterin formation in peripheral blood mononuclear cells in vitro.
Topics: Cannabidiol; Cannabinoid Receptor Antagonists; Cell Proliferation; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Gene Expression Regulation; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Indoles; Interferon-alpha; Kynurenine; Leukocytes, Mononuclear; Lipopolysaccharides; Mitogens; Morpholines; Neopterin; Pyrazoles; Statistics, Nonparametric; Tryptophan | 2009 |
Cannabinoid receptor type 1- and 2-mediated increase in cyclic AMP inhibits T cell receptor-triggered signaling.
Topics: Arachidonic Acids; Cannabinoids; Cell Proliferation; CSK Tyrosine-Protein Kinase; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dronabinol; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; GTP-Binding Protein alpha Subunits, Gi-Go; Humans; Indoles; Interleukin-2; Jurkat Cells; Lymphocyte Activation; Lymphocyte Specific Protein Tyrosine Kinase p56(lck); Morpholines; Multiple Sclerosis; Phosphorylation; Protein-Tyrosine Kinases; Psychotropic Drugs; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Antigen, T-Cell; Signal Transduction; src-Family Kinases; T-Lymphocytes | 2009 |
Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells.
Topics: Acetylcysteine; Arachidonic Acids; Cell Death; Cell Line; Coronary Vessels; Dose-Response Relationship, Drug; Dronabinol; Endocannabinoids; Endothelial Cells; Humans; Mitogen-Activated Protein Kinases; Morpholines; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Reactive Oxygen Species; Receptor, Cannabinoid, CB1; Rimonabant; Signal Transduction | 2010 |
Tourette's syndrome.
Topics: Adolescent; Adult; Aged; Brain; Cannabinoid Receptor Modulators; Dronabinol; Female; Humans; Iodine Isotopes; Male; Middle Aged; Morpholines; Pyrazoles; Randomized Controlled Trials as Topic; Receptor, Cannabinoid, CB1; Tomography, Emission-Computed, Single-Photon; Tourette Syndrome; Young Adult | 2009 |
Cannabinoid receptor agonists modulate oligodendrocyte differentiation by activating PI3K/Akt and the mammalian target of rapamycin (mTOR) pathways.
Topics: Animals; Arachidonic Acids; Cannabinoids; Cell Differentiation; Cells, Cultured; Chromones; Dronabinol; Enzyme Activators; Indoles; Morpholines; Myelin Proteins; Oligodendroglia; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Signal Transduction; Sirolimus; Stem Cells; TOR Serine-Threonine Kinases | 2011 |
Cannabinoids increase type 1 cannabinoid receptor expression in a cell culture model of striatal neurons: implications for Huntington's disease.
Topics: Adenosine Triphosphate; Animals; Cannabinoids; Cells, Cultured; Corpus Striatum; Dose-Response Relationship, Drug; Dronabinol; Enzyme Inhibitors; gamma-Aminobutyric Acid; Gene Expression Regulation; Huntingtin Protein; MAP Kinase Signaling System; Mice; Mice, Transgenic; Morpholines; Mutation; Nerve Tissue Proteins; Neurons; NF-kappa B; Nuclear Proteins; Pyrans; Pyrazoles; Receptor, Cannabinoid, CB1 | 2013 |